ArticleInternational journal of molecular sciences2024

Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock.

Anders Jarneborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.